Abdennadher Myriam, Rohatgi Pratik, Saxena Aneeta
Neurology Department, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA 02118, USA.
Neurosurgery Department, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA 02118, USA.
Brain Sci. 2024 Jul 2;14(7):675. doi: 10.3390/brainsci14070675.
Epilepsy affects over 65 million people worldwide. One-third of people with epilepsy do not respond to medication and may benefit from surgery. Vagus nerve stimulation (VNS) is the first neuromodulation therapy for the treatment of drug-resistant epilepsy. This method is used in combination with anti-seizure medications in adults and in the pediatric population. VNS has also been demonstrated to have benefits for some epilepsy comorbidities, such as depression, and can be used in combination with other neuromodulation therapies in epilepsy. The authors present an overview of VNS physiology, patient selection, surgery and risks, neuromodulation therapy, and application to epilepsy comorbidities.
癫痫影响着全球超过6500万人。三分之一的癫痫患者对药物治疗无反应,可能从手术中获益。迷走神经刺激(VNS)是治疗耐药性癫痫的首个神经调节疗法。该方法用于成人和儿童群体,与抗癫痫药物联合使用。VNS也已被证明对一些癫痫合并症有益,如抑郁症,并且可与癫痫的其他神经调节疗法联合使用。作者概述了VNS的生理学、患者选择、手术及风险、神经调节疗法以及在癫痫合并症中的应用。